RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O

-A +A

Comparison of autologous conditioned plasma injection, extracorporeal shockwave therapy, and conventional treatment for plantar fasciitis

CHEW KT; LEONG B; LIN CY; LIM KK; TAN B
PM & R , 2013, vol. 5, n° 12, p. 1035-1043
Doc n°: 167003
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.1016/j.pmrj.2013.08.590
Descripteurs : DE86 - TRAITEMENTS - PIED

OBJECTIVES: To evaluate the efficacy of autologous conditioned plasma (ACP)
compared with extracorporeal shockwave (ESWT) and conventional treatments for
plantar fasciitis. DESIGN: Randomized trial. SETTING: Sports medicine center in a
tertiary care hospital.
PATIENTS: Fifty-four subjects (age range, 29-71 years)
with unilateral chronic plantar fasciitis with more than 4 months of symptoms.
METHODS: Subjects randomized to 3 groups: 19 to ACP and conventional treatment
(ACP group), 19 to ESWT and conventional treatment (ESWT group), and 16 to
conventional treatment alone. Conventional treatment included stretching
exercises and orthotics if indicated. MAIN OUTCOME MEASUREMENTS: Outcomes were
pain-Visual Analog Scale (VAS), American Orthopaedic Foot and Ankle Society
(AOFAS) ankle-hindfoot scale, and ultrasound plantar fascia thickness assessed at
baseline before treatment and at 1 month, 3 months, and 6 months after treatment.
RESULTS: VAS, AOFAS ankle-hindfoot scale, and plantar fascia thickness improved
in all groups. Significant VAS pain score improvements in the ACP group compared
with conventional treatment at month 1 (P = .037) and for the ESWT group compared
with conventional treatment at months 1, 3, and 6 (P = .017, P = .022, and P =
.042). The AOFAS ankle-hindfoot scale score improved in the ACP group at months 3
and 6 (P = .004 and P = .013) and, for the ESWT group, at months 1 and 3 (P =
.011 and P = .003) compared with conventional treatment. Significant improvements
in plantar fascia thickness were seen in the ACP group at months 1 and 3 compared
with conventional treatments (P = .015 and P = .014) and at months 3 and 6
compared with the ESWT group (P = .019 and P = .027). No adverse events reported.
CONCLUSIONS: Treatment of plantar fasciitis with ACP or ESWT plus conventional
treatments resulted in improved pain and functional outcomes compared with
conventional treatment alone. There was no significant difference between ACP and
ESWT in terms of VAS and AOFAS ankle-hindfoot scale improvements, although the
ACP group demonstrated greater reductions in plantar fascia thickness.
CI - Copyright (c) 2013 American Academy of Physical Medicine and Rehabilitation.
Published by Elsevier Inc. All rights reserved.

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0